Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β‑catenin signal activation-Reference-Cited by-同舟云学术

Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β‑catenin signal activation

Published:2022-05-18 Issue:1 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kuwano Akifumi¹,Yada Masayoshi¹,Narutomi Fumiya²,Nagasawa Shigehiro¹,Tanaka Kosuke¹,Kurosaka Kazuki¹,Ohishi Yoshihiro²,Masumoto Akihide¹,Motomura Kenta¹

Affiliation:

1. Department of Hepatology, Iizuka Hospital, Iizuka, Fukuoka 820‑8505, Japan

2. Department of Diagnostic Pathology, Iizuka Hospital, Iizuka, Fukuoka 820‑8505, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference34 articles.

1. The epidemiology of hepatocellular cancer: From the perspectives of public health problem to tumor biology;Caldwell;J Gastroenterol,2009

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapies for Hepatocellular Carcinoma in India;Journal of Clinical and Experimental Hepatology;2024-11

2. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-06-20

3. Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?;Seminars in Liver Disease;2024-05

4. Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma;Hepatology Research;2024-02-14

5. Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations;Liver Cancer;2023-10-09